We would need to see some very significant Covid results at some stage to entice any of participants in the $0.24c CR to take part. There would be some seriously disgruntled sophisticated investors smarting over that. It more likely than not means the company cannot go back to that same well again. Be interesting if they try & structure any CR a bit differently. Lots of dilution coming our way at these prices. Wonder who will advise this time?
Ann: Investor Presentation, page-11
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
